Diagnostics Startups
31 companies tagged Diagnostics, with their investors and founders.
AOA Dx develops a blood-based liquid biopsy platform using mass spectrometry and machine learning to detect ovarian cancer at early stages through tumor-associated biomarkers in serum. The company serves oncologists and patients in women's health diagnostics.
22 investors
BillionToOne is a precision diagnostics company that uses molecular counting technology to develop non-invasive prenatal screening and liquid biopsy tests for early disease detection. The company focuses on making molecular diagnostics accurate, fast, and accessible to patients.
21 investors
Ginkgo Bioworks builds autonomous labs and offers cell-programming and bioengineering services for the biopharma, agriculture, and industrial biotech markets. The company operates in the synthetic biology industry, developing engineered organisms and foundry technology for customers across these sectors.
21 investors
Redcliffe Labs is a diagnostic laboratory platform in India offering at-home and lab-based health tests with personalized health packages, AI-powered report analysis, expert consultations, and genomic testing services. The company targets consumers seeking affordable, accurate diagnostics with personalized health guidance and family-focused healthcare solutions.
10 investors
Cofactor Genomics develops predictive diagnostics for cancer immunotherapy using RNA-expression models to characterize tumor microenvironments and predict patient response. The company serves oncology and precision medicine markets by enabling more accurate patient-to-therapy matching.
7 investors
Orange Health Labs operates a home-based diagnostic testing service in Indian cities, offering sample collection within 30 minutes and lab results within 6 hours. The company serves urban consumers seeking rapid medical testing across major metropolitan areas.
6 investors
Human Dx builds a medical system that uses crowdsourced clinical knowledge and machine learning to help diagnose patients, with the goal of making healthcare more accurate and accessible globally.
4 investors
The site is a Vietnamese-language affiliate/review portal that ranks and rates online lottery ("lΓ΄ Δα»") betting operators, offering comparisons of payout ratios, licensing, payment methods, and security. It targets Vietnamese online gamblers looking to choose betting sites.
4 investors
Lucira Health manufactures portable diagnostic devices that connect to smartphones to test bodily fluids for infectious diseases, enabling rapid results outside of clinical settings.
4 investors
Darmiyan develops medical AI and brain imaging software for early detection and monitoring of neurodegenerative diseases, particularly Alzheimer's. The platform targets healthcare providers, patients, and pharmaceutical companies seeking to advance brain health and disease prevention.
3 investors
InVision Medtech develops AI software that automatically evaluates left ventricular ejection fraction from echocardiographic images for cardiologists and medical facilities. The product has demonstrated time savings and improved clinical precision in a prospective clinical trial published in Nature.
3 investors
Moichor is an animal diagnostics laboratory providing automated blood count and cytology testing for veterinarians across the United States. The company uses artificial intelligence and computer vision to deliver species-specific pathology results through both send-in laboratory services and an in-clinic hematology device.
3 investors
Numen develops at-home cancer diagnostics and health data collection infrastructure using machine learning models to enable earlier intervention and improve patient outcomes.
3 investors
One Codex provides microbiome sequencing data analysis and reporting software for academic labs, biotechnology companies, and clinical laboratories. The platform uses advanced algorithms and a curated database to analyze metagenomic samples with a web-based interface accessible to both bench scientists and computational biologists.
3 investors
Scout develops portable molecular diagnostic testing devices that deliver lab-grade accuracy in under 30 minutes for point-of-care use. The platform enables healthcare providers to test and treat patients in real-time without requiring lab infrastructure or specialized training.
3 investors
Yemaachi creates a diverse cancer bio-database to develop oncology drugs effective across diverse patient populations. The company develops precision oncology research, diagnostics, and therapeutics with a focus on inclusion for global communities.
3 investors
Adravision builds a shared intelligence platform that integrates fragmented dental information systems, connecting clinical records, radiographs, treatment plans, and insurance data to support care delivery, documentation, and reimbursement.
2 investors
Clear Gene develops RNA diagnostics for detecting residual solid tumors in cancer patients and provides software and reagent kits to help clinical laboratories process COVID-19 samples more efficiently using existing equipment.
2 investors
DEWI11 is an online gaming platform that provides information and articles about online games, including game updates, seasonal changes, new features, and strategies for players.
2 investors
LSK Technologies builds a portable distributed testing platform for diagnosing infectious diseases in field and remote settings. The device, called PLUM, enables rapid and decentralized diagnostic testing for pathogens like Zika virus and SARS-CoV-2.
2 investors
Signatur Biosciences develops molecular diagnostic solutions using qPCR technology for in vitro diagnostics, targeting clinical and laboratory markets. The company aims to deliver advanced diagnostics on widely available instrumentation to expand access to cutting-edge healthcare globally.
2 investors
Spot provides white-label at-home diagnostic testing services for health brands, enabling users to collect and submit lab-analyzed blood, urine, and saliva samples at home. The platform handles sample collection kits, regulatory compliance including doctor orders where required, lab partnerships, and integration of results into customer-facing applications.
2 investors
Amino Analytica designs rapid molecular diagnostic tests for emerging infectious diseases and biological threats, developed in weeks rather than the traditional 12+ months. The company combines point-of-care diagnostics technology with AI-driven bionanotechnology to enable earlier detection and faster pandemic response.
1 investor
Biocartesian provides optical pooled screening services for functional genomics research. The company uses its proprietary ARADIA technology to link microscopy-based cellular phenotypes with genetic perturbations, enabling researchers to conduct large-scale CRISPR screens and other genomic studies with visual, spatial, and live-cell readouts.
1 investor